BioCardia, Inc. (BCDA) › Cash & EquivalentsBioCardia, Inc. (BCDA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $4.97M2010: $127.0K2011: $12.68M2012: $13.27M2013: $13.29M2014: $3.18M2015: $3.56M2016: $21.35M2017: $12.69M2018: $5.36M2019: $5.58M2020: $21.41M2021: $12.87M2022: $7.36M2023: $1.10M2024: $2.37M2025: $2.50M$2.50M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$2.50M+5.3%2024$2.37M+115.0%2023$1.10M-85.0%2022$7.36M-42.8%2021$12.87M-39.9%2020$21.41M+283.3%2019$5.58M+4.2%2018$5.36M-57.8%2017$12.69M-40.6%2016$21.35M+500.3%2015$3.56M+11.7%2014$3.18M-76.1%2013$13.29M+0.2%2012$13.27M+4.7%2011$12.68M+9882.7%2010$127.0K-97.4%2009$4.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share